Phase 2 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 79 years old.
- People who have been diagnosed with a head or neck cancer confirmed by laboratory testing — this includes cancers of the nasopharynx, mouth, throat, voice box, salivary glands, nasal cavity, sinuses, and similar areas.
- People whose cancer has stopped responding to at least two previous standard treatments, including treatments with cetuximab and an immunotherapy drug.
- People whose doctors estimate they are likely to live for at least 3 more months.
- People who are reasonably active and able to care for themselves, based on a standard medical activity scale scored 0 to 2 (confirm with trial site).
- People whose blood test results before treatment show a neutrophil count above 2000/mm³ and a platelet count above 100,000/mm³ (these are types of blood cells measured in routine tests).
- People whose liver and kidney function tests before treatment fall within acceptable ranges: bilirubin below 1.5 mg/dL, liver enzymes (AST or ALT) no more than 1.5 times the normal upper limit, and kidney markers (creatinine below 1.5 mg/dL and clearance above 60 mL/min).
- People who are willing to follow the trial schedule and visits, and who are able to give written consent to participate.
Who may not be able to join:
- People whose doctors estimate they are likely to live for less than 3 months.
- Women of childbearing age who have a positive pregnancy test.
- People with other serious ongoing health conditions that could affect their safety or ability to take part in the trial (confirm with trial site).
- People with active mental health conditions that would prevent them from understanding the study or signing a consent form.
- People with serious blood clotting problems or an active infection that currently requires treatment through an intravenous drip.
- People who have had a different type of cancer within the past 5 years — except for certain skin cancers or a very early-stage form of thyroid cancer that has already been treated with the aim of curing it.
- People with serious heart rhythm problems or high blood pressure that is not controlled by treatment (blood pressure above 150/90 mmHg).
- People who still have side effects from previous cancer treatments that have not improved to a mild or resolved level, with some exceptions such as hair loss or mild nerve-related symptoms (confirm with trial site).
- People who test positive for HIV, or who have active hepatitis B or hepatitis C infections, based on specific blood test results (confirm with trial site).
- People who the trial doctors consider unsuitable for any other reason that could affect their safety or ability to follow the trial plan.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 086-18982770417
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.